经括约肌入路联合肉膜肌瓣置入修补根治性前列腺切除术后直肠尿道瘘
本文报告一种新技术,将York-Mason经括约肌入路与肉膜肌瓣置入联合用于治疗直肠尿道瘘。从2002—2023年前瞻性数据库中提取35例直肠尿道瘘手术记录,其中5例因根治性前列腺切除术后直肠尿道瘘接受该联合术式,均为转诊病例。5例均治愈,中位随访70.0个月无复发;首次排尿性膀胱尿道造影均显示瘘口愈合,后侧及阴囊切口愈合良好,所有患者排尿正常且无尿失禁;截至报告时3例已关闭造口,均控便完好且无肛管狭窄。
要点
- 5例根治性前列腺切除术后直肠尿道瘘行York-Mason经括约肌入路联合肉膜肌瓣置入,均治愈。
- 中位随访70.0个月无复发,首次排尿性膀胱尿道造影均显示瘘口愈合。
- 所有患者排尿正常、无尿失禁;3例已关闭造口,控便完好且无肛管狭窄。
核心结论
- 经括约肌改良York-Mason入路联合肉膜肌瓣置入可使直肠尿道瘘完全愈合。
研究设计与样本
- 从2002—2023年前瞻性维护的数据库中提取35例直肠尿道瘘手术记录,其中5例因根治性前列腺切除术后直肠尿道瘘接受York-Mason入路联合肉膜肌瓣置入,均为转诊病例。
主要发现
- 5例均成功治愈,中位随访70.0个月无复发。
- 修补术前所有患者均有转流性造口。
- 所有病例首次排尿性膀胱尿道造影即显示瘘口愈合。
- 后侧及阴囊切口均愈合顺利。
- 所有患者报告排尿正常且无尿失禁。
临床怎么用
- 作者报告该联合术式使直肠尿道瘘完全愈合,原文未据此给出进一步推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To present our experience with a novel technique that combines the York-Mason transsphincteric approach with dartos muscle flap interposition to treat rectourethral fistulas. METHODS: We extracted records from our prospectively kept database of 35 procedures conducted for treating rectourethral fistulas during 2002-2023; the York-Mason approach was combined with dartos muscle flap interposition in 5 cases, performed for treating rectourethral fistulas due to radical prostatectomy, all of which were referral cases. RESULTS: All 5 patients were successfully treated and followed up for a median of 70.0 months without recurrence. Before the fistula repair, all had a diverting stoma. In all cases, the first voiding cystourethrogram revealed a healed fistula. The posterior and the scrotal incisions healed uneventfully. All patients reported normal voiding and no urinary incontinence. To date, the stoma has closed in 3 patients, all of whom had intact fecal continence and no postoperative anal stenosis. CONCLUSION: The transsphincteric modified York-Mason approach combined with dartos muscle flap interposition resulted in complete healing of rectourethral fistulas.
引用
- Dafnis G. Transsphincteric Repair of Rectourethral Fistulas in Combination With Dartos Muscle Flap Interposition Following Radical Prostatectomy. Urology. 2024. PMID: 38834146. doi:10.1016/j.urology.2024.05.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。